Adma Biologics (ADMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,380 | -75,749 | -56,341 | -39,423 | -19,245 |
| Depreciation Amortization | 1,638 | 5,582 | 3,947 | 2,478 | 1,183 |
| Accounts receivable | -2,125 | -9,767 | -2,865 | -3,044 | -3,638 |
| Accounts payable and accrued liabilities | 1,079 | 1,899 | -1,195 | -2,265 | -22 |
| Other Working Capital | -17,269 | -33,781 | -19,569 | -10,382 | -7,262 |
| Other Operating Activity | 1,828 | 9,813 | 6,239 | 6,705 | 4,338 |
| Operating Cash Flow | $-33,229 | $-102,003 | $-69,784 | $-45,931 | $-24,647 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,571 | -12,725 | -9,126 | -6,241 | -2,073 |
| Investing Cash Flow | $-2,571 | $-12,725 | $-9,126 | $-6,241 | $-2,073 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 27,500 | 12,500 | 12,500 | 12,500 |
| Debt Repayment | -8 | -14,812 | -24 | -16 | -8 |
| Common Stock Issued | 41,913 | 131,209 | 99,357 | 88,718 | 88,711 |
| Other Financing Activity | -59 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $41,845 | $143,897 | $111,833 | $101,202 | $101,203 |
| Beginning Cash Position | 55,921 | 26,752 | 26,752 | 26,752 | 26,752 |
| End Cash Position | 61,966 | 55,921 | 59,675 | 75,781 | 101,236 |
| Net Cash Flow | $6,045 | $29,169 | $32,923 | $49,029 | $74,484 |
| Free Cash Flow | |||||
| Operating Cash Flow | -33,229 | -102,003 | -69,784 | -45,931 | -24,647 |
| Capital Expenditure | -2,571 | -12,727 | -9,128 | -6,243 | -2,075 |
| Free Cash Flow | -35,800 | -114,730 | -78,912 | -52,175 | -26,722 |